Primary cutaneous lymphoma: two-decade comparison in a population of 263 cases from a Swiss tertiary referral centre

Summary Background  Epidemiological data on primary cutaneous lymphomas (PCLs) are rare and have not previously been investigated in Switzerland. Objective  To analyse variations in demographics, the pattern of subtypes and staging during the two 10‐year intervals, 1990–1999 and 2000–2009. Methods ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of dermatology (1951) 2011-05, Vol.164 (5), p.1071-1077
Hauptverfasser: Jenni, D., Karpova, M.B., Seifert, B., Golling, Ph, Cozzio, A., Kempf, W., French, L.E., Dummer, R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1077
container_issue 5
container_start_page 1071
container_title British journal of dermatology (1951)
container_volume 164
creator Jenni, D.
Karpova, M.B.
Seifert, B.
Golling, Ph
Cozzio, A.
Kempf, W.
French, L.E.
Dummer, R.
description Summary Background  Epidemiological data on primary cutaneous lymphomas (PCLs) are rare and have not previously been investigated in Switzerland. Objective  To analyse variations in demographics, the pattern of subtypes and staging during the two 10‐year intervals, 1990–1999 and 2000–2009. Methods  This was a descriptive study of 263 patients with PCL based on a retrospective review and reassessment according to the World Health Organization/European Organization for Research and Treatment of Cancer classification. Results  Change was observed in the pattern of cutaneous T‐cell lymphoma subtypes: the frequency of Sézary syndrome decreased from 17% to 7% and the frequency of CD30+ lymphoproliferative disorders increased from 7% to 18% (overall P = 0·04). Staging of PCL showed a higher number of cases of early‐stage mycosis fungoides (P = 0·01). In relation to the international data, the Zürich group had a higher number of patients with Sézary syndrome (11% vs. 3%) and marginal cell lymphoma (14% vs. 5–7%). In addition, comparison of the survival data showed prolonged median overall survival of Zürich patients with Sézary syndrome in the second 10‐year interval (6·5 vs. 2–4 years). Conclusion  The increasing frequency of marginal cell lymphoma and CD30+ lymphoproliferative disorders might depend on an increased awareness of these diseases in the medical community, driven by progress in the classification and staging of these disease entities.
doi_str_mv 10.1111/j.1365-2133.2010.10143.x
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_863768712</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>863768712</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3883-a98b641c5c7054aa7b8f1e1d7cf45154c00b0f4c0293d3dce6366b7e280c328e3</originalsourceid><addsrcrecordid>eNpFkU1v1DAQhi0EokvhLyBfEKdsx5nE8XJAolvYllaA-BBHy3Emwku-sBPt7r9v0ixbX8b2PHqkmZcxLmApxnOxXQqUaRQLxGUM0y-IBJf7J2xxajxlCwDIIlhJPGMvQtgCCIQUnrOzWIDCNJEL1n_zrjb-wO3Qm4baIfDqUHd_2tq84_2ujQqypiBu27oz3oW24a7hhndtN1Smd-O7LXkskVsTKPDSt_XY_rFzIfCefO8muaeSvDcVt9T0nl6yZ6WpAr061nP269PHn-vr6O7r5mb94S6yqBRGZqVymQib2gzSxJgsV6UgUWS2TFKRJhYgh3Is8QoLLCxJlDLPKFZgMVaE5-zt7O18-2-g0OvaBUtVNU-qlcRMqkzEI_n6SA55TYXu5q3o_4sagTdHwARrqtKbxrrwyCVCSUgn0fuZ27mKDqe-AD0Fp7d6ykdP-egpOP0QnN7ry89XD9dREM0CF3ranwTG_9UywyzVv79sdILJ1Xpz-13HeA83d5qg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>863768712</pqid></control><display><type>article</type><title>Primary cutaneous lymphoma: two-decade comparison in a population of 263 cases from a Swiss tertiary referral centre</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Jenni, D. ; Karpova, M.B. ; Seifert, B. ; Golling, Ph ; Cozzio, A. ; Kempf, W. ; French, L.E. ; Dummer, R.</creator><creatorcontrib>Jenni, D. ; Karpova, M.B. ; Seifert, B. ; Golling, Ph ; Cozzio, A. ; Kempf, W. ; French, L.E. ; Dummer, R.</creatorcontrib><description>Summary Background  Epidemiological data on primary cutaneous lymphomas (PCLs) are rare and have not previously been investigated in Switzerland. Objective  To analyse variations in demographics, the pattern of subtypes and staging during the two 10‐year intervals, 1990–1999 and 2000–2009. Methods  This was a descriptive study of 263 patients with PCL based on a retrospective review and reassessment according to the World Health Organization/European Organization for Research and Treatment of Cancer classification. Results  Change was observed in the pattern of cutaneous T‐cell lymphoma subtypes: the frequency of Sézary syndrome decreased from 17% to 7% and the frequency of CD30+ lymphoproliferative disorders increased from 7% to 18% (overall P = 0·04). Staging of PCL showed a higher number of cases of early‐stage mycosis fungoides (P = 0·01). In relation to the international data, the Zürich group had a higher number of patients with Sézary syndrome (11% vs. 3%) and marginal cell lymphoma (14% vs. 5–7%). In addition, comparison of the survival data showed prolonged median overall survival of Zürich patients with Sézary syndrome in the second 10‐year interval (6·5 vs. 2–4 years). Conclusion  The increasing frequency of marginal cell lymphoma and CD30+ lymphoproliferative disorders might depend on an increased awareness of these diseases in the medical community, driven by progress in the classification and staging of these disease entities.</description><identifier>ISSN: 0007-0963</identifier><identifier>EISSN: 1365-2133</identifier><identifier>DOI: 10.1111/j.1365-2133.2010.10143.x</identifier><identifier>PMID: 21083546</identifier><identifier>CODEN: BJDEAZ</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Child ; Dermatology ; Female ; Hematologic and hematopoietic diseases ; Humans ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Lymphoma - classification ; Lymphoma - epidemiology ; Lymphoma - pathology ; Male ; Medical sciences ; Middle Aged ; Neoplasm Staging ; Retrospective Studies ; Skin Neoplasms - classification ; Skin Neoplasms - epidemiology ; Skin Neoplasms - pathology ; Survival Analysis ; Switzerland - epidemiology ; Young Adult</subject><ispartof>British journal of dermatology (1951), 2011-05, Vol.164 (5), p.1071-1077</ispartof><rights>2011 The Authors. BJD © 2011 British Association of Dermatologists</rights><rights>2015 INIST-CNRS</rights><rights>2011 The Authors. BJD © 2011 British Association of Dermatologists.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3883-a98b641c5c7054aa7b8f1e1d7cf45154c00b0f4c0293d3dce6366b7e280c328e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2133.2010.10143.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2133.2010.10143.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=24186052$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21083546$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jenni, D.</creatorcontrib><creatorcontrib>Karpova, M.B.</creatorcontrib><creatorcontrib>Seifert, B.</creatorcontrib><creatorcontrib>Golling, Ph</creatorcontrib><creatorcontrib>Cozzio, A.</creatorcontrib><creatorcontrib>Kempf, W.</creatorcontrib><creatorcontrib>French, L.E.</creatorcontrib><creatorcontrib>Dummer, R.</creatorcontrib><title>Primary cutaneous lymphoma: two-decade comparison in a population of 263 cases from a Swiss tertiary referral centre</title><title>British journal of dermatology (1951)</title><addtitle>Br J Dermatol</addtitle><description>Summary Background  Epidemiological data on primary cutaneous lymphomas (PCLs) are rare and have not previously been investigated in Switzerland. Objective  To analyse variations in demographics, the pattern of subtypes and staging during the two 10‐year intervals, 1990–1999 and 2000–2009. Methods  This was a descriptive study of 263 patients with PCL based on a retrospective review and reassessment according to the World Health Organization/European Organization for Research and Treatment of Cancer classification. Results  Change was observed in the pattern of cutaneous T‐cell lymphoma subtypes: the frequency of Sézary syndrome decreased from 17% to 7% and the frequency of CD30+ lymphoproliferative disorders increased from 7% to 18% (overall P = 0·04). Staging of PCL showed a higher number of cases of early‐stage mycosis fungoides (P = 0·01). In relation to the international data, the Zürich group had a higher number of patients with Sézary syndrome (11% vs. 3%) and marginal cell lymphoma (14% vs. 5–7%). In addition, comparison of the survival data showed prolonged median overall survival of Zürich patients with Sézary syndrome in the second 10‐year interval (6·5 vs. 2–4 years). Conclusion  The increasing frequency of marginal cell lymphoma and CD30+ lymphoproliferative disorders might depend on an increased awareness of these diseases in the medical community, driven by progress in the classification and staging of these disease entities.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Dermatology</subject><subject>Female</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Lymphoma - classification</subject><subject>Lymphoma - epidemiology</subject><subject>Lymphoma - pathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Retrospective Studies</subject><subject>Skin Neoplasms - classification</subject><subject>Skin Neoplasms - epidemiology</subject><subject>Skin Neoplasms - pathology</subject><subject>Survival Analysis</subject><subject>Switzerland - epidemiology</subject><subject>Young Adult</subject><issn>0007-0963</issn><issn>1365-2133</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkU1v1DAQhi0EokvhLyBfEKdsx5nE8XJAolvYllaA-BBHy3Emwku-sBPt7r9v0ixbX8b2PHqkmZcxLmApxnOxXQqUaRQLxGUM0y-IBJf7J2xxajxlCwDIIlhJPGMvQtgCCIQUnrOzWIDCNJEL1n_zrjb-wO3Qm4baIfDqUHd_2tq84_2ujQqypiBu27oz3oW24a7hhndtN1Smd-O7LXkskVsTKPDSt_XY_rFzIfCefO8muaeSvDcVt9T0nl6yZ6WpAr061nP269PHn-vr6O7r5mb94S6yqBRGZqVymQib2gzSxJgsV6UgUWS2TFKRJhYgh3Is8QoLLCxJlDLPKFZgMVaE5-zt7O18-2-g0OvaBUtVNU-qlcRMqkzEI_n6SA55TYXu5q3o_4sagTdHwARrqtKbxrrwyCVCSUgn0fuZ27mKDqe-AD0Fp7d6ykdP-egpOP0QnN7ry89XD9dREM0CF3ranwTG_9UywyzVv79sdILJ1Xpz-13HeA83d5qg</recordid><startdate>201105</startdate><enddate>201105</enddate><creator>Jenni, D.</creator><creator>Karpova, M.B.</creator><creator>Seifert, B.</creator><creator>Golling, Ph</creator><creator>Cozzio, A.</creator><creator>Kempf, W.</creator><creator>French, L.E.</creator><creator>Dummer, R.</creator><general>Blackwell Publishing Ltd</general><general>Wiley-Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201105</creationdate><title>Primary cutaneous lymphoma: two-decade comparison in a population of 263 cases from a Swiss tertiary referral centre</title><author>Jenni, D. ; Karpova, M.B. ; Seifert, B. ; Golling, Ph ; Cozzio, A. ; Kempf, W. ; French, L.E. ; Dummer, R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3883-a98b641c5c7054aa7b8f1e1d7cf45154c00b0f4c0293d3dce6366b7e280c328e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Dermatology</topic><topic>Female</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Lymphoma - classification</topic><topic>Lymphoma - epidemiology</topic><topic>Lymphoma - pathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Retrospective Studies</topic><topic>Skin Neoplasms - classification</topic><topic>Skin Neoplasms - epidemiology</topic><topic>Skin Neoplasms - pathology</topic><topic>Survival Analysis</topic><topic>Switzerland - epidemiology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jenni, D.</creatorcontrib><creatorcontrib>Karpova, M.B.</creatorcontrib><creatorcontrib>Seifert, B.</creatorcontrib><creatorcontrib>Golling, Ph</creatorcontrib><creatorcontrib>Cozzio, A.</creatorcontrib><creatorcontrib>Kempf, W.</creatorcontrib><creatorcontrib>French, L.E.</creatorcontrib><creatorcontrib>Dummer, R.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of dermatology (1951)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jenni, D.</au><au>Karpova, M.B.</au><au>Seifert, B.</au><au>Golling, Ph</au><au>Cozzio, A.</au><au>Kempf, W.</au><au>French, L.E.</au><au>Dummer, R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Primary cutaneous lymphoma: two-decade comparison in a population of 263 cases from a Swiss tertiary referral centre</atitle><jtitle>British journal of dermatology (1951)</jtitle><addtitle>Br J Dermatol</addtitle><date>2011-05</date><risdate>2011</risdate><volume>164</volume><issue>5</issue><spage>1071</spage><epage>1077</epage><pages>1071-1077</pages><issn>0007-0963</issn><eissn>1365-2133</eissn><coden>BJDEAZ</coden><abstract>Summary Background  Epidemiological data on primary cutaneous lymphomas (PCLs) are rare and have not previously been investigated in Switzerland. Objective  To analyse variations in demographics, the pattern of subtypes and staging during the two 10‐year intervals, 1990–1999 and 2000–2009. Methods  This was a descriptive study of 263 patients with PCL based on a retrospective review and reassessment according to the World Health Organization/European Organization for Research and Treatment of Cancer classification. Results  Change was observed in the pattern of cutaneous T‐cell lymphoma subtypes: the frequency of Sézary syndrome decreased from 17% to 7% and the frequency of CD30+ lymphoproliferative disorders increased from 7% to 18% (overall P = 0·04). Staging of PCL showed a higher number of cases of early‐stage mycosis fungoides (P = 0·01). In relation to the international data, the Zürich group had a higher number of patients with Sézary syndrome (11% vs. 3%) and marginal cell lymphoma (14% vs. 5–7%). In addition, comparison of the survival data showed prolonged median overall survival of Zürich patients with Sézary syndrome in the second 10‐year interval (6·5 vs. 2–4 years). Conclusion  The increasing frequency of marginal cell lymphoma and CD30+ lymphoproliferative disorders might depend on an increased awareness of these diseases in the medical community, driven by progress in the classification and staging of these disease entities.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>21083546</pmid><doi>10.1111/j.1365-2133.2010.10143.x</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0007-0963
ispartof British journal of dermatology (1951), 2011-05, Vol.164 (5), p.1071-1077
issn 0007-0963
1365-2133
language eng
recordid cdi_proquest_miscellaneous_863768712
source MEDLINE; Access via Wiley Online Library; Oxford University Press Journals All Titles (1996-Current)
subjects Adolescent
Adult
Aged
Aged, 80 and over
Biological and medical sciences
Child
Dermatology
Female
Hematologic and hematopoietic diseases
Humans
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Lymphoma - classification
Lymphoma - epidemiology
Lymphoma - pathology
Male
Medical sciences
Middle Aged
Neoplasm Staging
Retrospective Studies
Skin Neoplasms - classification
Skin Neoplasms - epidemiology
Skin Neoplasms - pathology
Survival Analysis
Switzerland - epidemiology
Young Adult
title Primary cutaneous lymphoma: two-decade comparison in a population of 263 cases from a Swiss tertiary referral centre
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T19%3A54%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Primary%20cutaneous%20lymphoma:%20two-decade%20comparison%20in%20a%20population%20of%20263%20cases%20from%20a%20Swiss%20tertiary%20referral%20centre&rft.jtitle=British%20journal%20of%20dermatology%20(1951)&rft.au=Jenni,%20D.&rft.date=2011-05&rft.volume=164&rft.issue=5&rft.spage=1071&rft.epage=1077&rft.pages=1071-1077&rft.issn=0007-0963&rft.eissn=1365-2133&rft.coden=BJDEAZ&rft_id=info:doi/10.1111/j.1365-2133.2010.10143.x&rft_dat=%3Cproquest_pubme%3E863768712%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=863768712&rft_id=info:pmid/21083546&rfr_iscdi=true